23 May, 2026
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on…
WASHINGTON — A group of Senate Democrats is proposing that Medicare cover in-home care, which would create the first new benefit in the program since the Part D retail drug…
The Trump administration has made sweeping changes to vaccine policy over the past year justified by invocations of patients’ “personal autonomy.” In January, Department of Health and Human Services head…
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Shelley Wood and Eric Topol. Be sure to sign up for the weekly “First Opinion Podcast”…
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on…

STAT+: Epic’s ‘large medical model’ aims to change how hospitals predict patient risk

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday.  Remember how I mentioned the “inexplicable kites” on Epic’s campus last week? Well, reader Michael K. Sherman, who is the guy who flies the kites […]

1 min read

Health AI investment: Traits of success and the reckoning

Health Tech Correspondent Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech’s promise. He’s also the co-author of the free, twice weekly STAT Health Tech […]

1 min read

AbbVie to buy Gilgamesh’s psychedelic drug for up to $1.2 billion

AbbVie on Monday said it will buy Gilgamesh Pharmaceuticals’ investigational psychedelic drug to treat major depression, a sign that pharma companies are warming up more to the burgeoning field. The pharma giant will acquire the treatment, called bretisilocin, for up to $1.2 billion, including an upfront payment and development milestones. Meanwhile, Gilgamesh will spin off […]

1 min read

FDA to publish daily reports of adverse events tied to drugs

WASHINGTON — The Food and Drug Administration announced Friday that it has begun publishing reports of adverse events concerning drugs and biological products on a daily basis. Previously, the database of the reports, called the FDA Adverse Event Reporting System, was updated quarterly.  “People who navigate the government’s clunky adverse event reporting websites should not […]

1 min read